Raymond James Trust N.A. raised its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 1.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,884 shares of the medical research company’s stock after purchasing an additional 144 shares during the period. Raymond James Trust N.A.’s holdings in Thermo Fisher Scientific were worth $1,899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently bought and sold shares of the company. Proficio Capital Partners LLC raised its position in Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after purchasing an additional 253 shares in the last quarter. Cribstone Capital Management LLC raised its position in Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares in the last quarter. Shine Investment Advisory Services Inc. acquired a new stake in Thermo Fisher Scientific in the 2nd quarter valued at about $113,000. Chicago Partners Investment Group LLC acquired a new stake in Thermo Fisher Scientific in the 2nd quarter valued at about $108,000. Finally, CWM LLC raised its position in Thermo Fisher Scientific by 17.0% in the 2nd quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after purchasing an additional 103 shares in the last quarter. 83.32% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY WARNING: “Raymond James Trust N.A. Has $1.90 Million Holdings in Thermo Fisher Scientific Inc (TMO)” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.chaffeybreeze.com/2017/10/19/raymond-james-trust-n-a-has-1-90-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Inc (NYSE:TMO) opened at 189.22 on Thursday. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30. The company’s 50-day moving average price is $190.20 and its 200-day moving average price is $176.17. The stock has a market cap of $73.82 billion, a P/E ratio of 32.97 and a beta of 1.05.
Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter in the prior year, the firm posted $2.03 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 10.2% compared to the same quarter last year. Analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.
Several equities research analysts have recently weighed in on TMO shares. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Tuesday, September 12th. Leerink Swann raised their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Cowen and Company reissued an “outperform” rating and set a $220.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Barclays PLC reissued an “overweight” rating and set a $215.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Monday, September 25th. Finally, Goldman Sachs Group, Inc. (The) started coverage on Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $203.64.
In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $65,149.20. Following the sale, the director now owns 5,312 shares in the company, valued at $961,312.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Gregory J. Herrema sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total value of $5,280,600.00. Following the sale, the senior vice president now owns 67,016 shares in the company, valued at approximately $11,796,156.32. The disclosure for this sale can be found here. Insiders have sold 52,738 shares of company stock worth $9,302,112 in the last 90 days. 0.49% of the stock is currently owned by insiders.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.